.jpg)
STAT Plus: Pharmalittle: FDA decision to OK Covid-19 plasma prompts skepticism; will Trump fast track AstraZeneca vaccine?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Category: Pharma
FDA commissioner needs to push back and tell Trump the agency is not part of the ‘deep state’
The next 73 days are going to be very difficult for Stephen Hahn. As the…
STAT Plus: Pharmalittle: FDA official would resign if agency pressured to OK Covid-19 vaccine; J&J plans huge vaccine trial
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program
A growing number of drug makers are taking steps to curtail the discounts they offer…
STAT Plus: Boehringer to pay $379,000 to settle charges of wage discrimination against female employees
Following a review by the Department of Labor, a unit of Boehringer Ingelheim agreed to…
STAT Plus: Pharmalittle: Mail slowdown could limit access to drugs; CureVac nears a Covid-19 vaccine deal with Europe
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT Plus: After FDA rejection of a key drug, is Gilead still a turnaround story?
The surprise decision by the FDA to reject a Gilead Sciences (GILD) drug for treating…
STAT Plus: Pharmalittle: FDA surprises BioMarin and Gilead by rejecting key drugs; J&J pays $6.5 billion to buy Momenta
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT Plus: J&J to buy Momenta Pharma in a bid to bolster autoimmune disease pipeline
Health care giant Johnson & Johnson said Wednesday that it is acquiring Momenta Pharmaceuticals, gaining…
STAT Plus: Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients
Federal authorities alleged that Teva Pharmaceuticals (TEVA) donated hundreds of millions of dollars to a…
.jpg)
STAT Plus: FDA finalizes penalties for trial sponsors that don’t share data, but critics say the effort falls short
After a year of deliberation, the Food and Drug Administration released final guidelines for penalizing…
STAT Plus: Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: Opioid prescriptions written for Medicare Part D beneficiaries continues to drop
Amid an ongoing opioid crisis in the U.S., a new federal government report finds that…
STAT Plus: Pharmalittle: U.S. ties Covid-19 vaccine payments to milestones; Sanofi spends $3.7 billion for Principia and an MS drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Medicaid beneficiaries sue Texas health agency for restricting access to hepatitis C medicines
A group of Medicaid enrollees is accusing a Texas agency of rationing hepatitis C medicines…
STAT Plus: Pharmalittle: Governments race to acquire Covid-19 vaccines; top Russian doctor quits over vaccine ethics
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem
Amid growing concerns over antibiotic resistance, a new survey finds the vast majority of doctors…
STAT Plus: Many psoriasis patients are paying higher prices than ever at the pharmacy counter
Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing…
STAT Plus: Pharmalittle: FDA approves another Duchenne muscular dystrophy drug; European orphan drug incentives questioned
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change
After being kept under wraps for a year, an expansive review of European regulations designed…
STAT Plus: Pharmalittle: Moderna gets $1.5 billion U.S. contract for Covid-19 vax; state out-of-pocket caps saved residents money
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
Amid efforts to blunt rising medicines costs, a new analysis finds three states succeeded in…
STAT Plus: Pharmalittle: Russia registers a Covid-19 vaccine amid skepticism; can monoclonal antibodies combat the coronavirus?
Rise and shine, everyone, another demanding day is on the way. We can tell if…
STAT Plus: Seizing on India’s lax standards for Covid-19 drugs, critics push for an overhaul on transparency
As Indian regulators endorse controversial treatments for Covid-19, a group of high-profile physicians and activists…
STAT Plus: Pharmalittle: One in three Americans would refuse a Covid-19 vaccine; pharma donates big-time to Congress
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
WASHINGTON — The world’s biggest drug makers and their trade groups have cut checks to…
STAT Plus: Pharmalittle: Trump’s ‘Buy American’ order raises doubts; Gilead looks to boost global remdesivir output
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: AbbVie pays $24 million to settle lawsuit over using ‘nurse ambassadors’ to boost Humira sales
After two years of wrangling, AbbVie (ABBV) agreed to pay $24 million to settle a…
STAT Plus: Italy becomes first country to require pharma to disclose public funding for R&D costs
Amid growing clamor for more transparency from the pharmaceutical industry, Italy has become the first…
STAT Plus: Pressure mounts on FDA chief to stick with science for Covid-19 vaccine approvals
As pressure mounts to develop a successful Covid-19 vaccine, Food and Drug Administration Commissioner Stephen…
STAT Plus: Pharmalittle: AstraZeneca strikes first Covid-19 deal with a Chinese company; vaccine trials face distrust from minority groups
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: J&J to supply U.S. with 100 million Covid-19 vaccine doses; Feds seek $18 billion from Purdue in opioid probe
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT Plus: State attorneys general urge HHS to sidestep Gilead patents to increase remdesivir access
A bipartisan group of state attorneys general is urging the federal government to sidestep the…
STAT Plus: BARDA faces pressure to force Moderna to disclose cost details from its Covid-19 contract
Amid concerns over U.S. government Covid-19 contracts and transparency, Moderna (MRNA) has failed to comply…
STAT Plus: Pharmalittle: Regeneron Covid-19 antibody treatment works in animals; Warren asks SEC to probe Kodak trading
Top of the morning to you, and a fine one it is. Despite a looming…
STAT Plus: Prescription drugs may be more affordable than you think — unless you pay cash
Amid growing complaints that many Americans cannot afford their prescription medicines, most people in the…
STAT Plus: Gilead faces renewed pressure to pursue remdesivir-like compound to fight Covid-19
In an unusual move, a pair of academics is escalating an effort to convince Gilead…
STAT Plus: Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills
The Department of Justice has started investigating whether drug makers failed to disclose information about…
STAT Plus: Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Music in drug ads makes it easier for the public to tune out side effects, advocates argue
This will not be music to the ears of the pharmaceutical industry. A pair of…
STAT Plus: In a blow to Catalyst, judge recommends tossing its lawsuit against FDA
A federal court judge recommended tossing out a lawsuit filed by Catalyst Pharmaceuticals (CPRX) that…
STAT Plus: Pharmalittle: U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine; Moderna director resigns over conflict concerns
And so, another working week will soon draw to a close. Not a moment too…
Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and 100 million doses
The U.S. government’s Operation Warp Speed effort will provide up to $2.1 billion to Sanofi…
STAT Plus: Pharmalittle: Drug makers build Covid-19 vaccine supply chains; VCs are still spending on biotechs
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: Drug maker settles charges of offering ‘bogus’ research grants to boost use of its medicine
In the latest imbroglio involving drug makers and kickbacks, Pacira Biosciences (PCRX) has agreed to…
STAT Plus: Venture capitalists are still showering biotechs with cash, even as the coronavirus upends markets
Venture capitalists are still spending big on biotech companies, even four months after the coronavirus…
STAT Plus: Seeking to battle high drug prices and the opioid crisis, two states ponder banning gifts to doctors
Over the past month, lawmakers in two states have introduced bills that would ban drug…
STAT Plus: Pharmalittle: Global supply chain not ready for Covid-19 vaccines; Moderna may price its vaccine at up to $60
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration
The pharmaceutical giant GlaxoSmithKline is starting human trials of the first medicine, a cancer drug,…
STAT Plus: Cepheid is accused of overcharging and undersupplying its Covid-19 test to poor countries
As controversy rises over equal access to Covid-19 medical products, a manufacturer of rapid, point-of…